Brief: EyeGate Pharma Reports Appointment of Brian M. Strem as President and CEO
July 26 (Reuters) - EyeGate Pharmaceuticals Inc EYEG.O :
* EYEGATE PHARMACEUTICALS ANNOUNCES APPOINTMENT OF BRIAN M.
STREM,
PH.D., AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
* EYEGATE PHARMACEUTICALS INC - ENTERED A NON-BINDING LETTER
OF
INTENT TO ACQUIRE BAYON THERAPEUTICS
* EYEGATE PHARMA- WOULD ACQUIRE BAYON FOR CLOSING
CONSIDERATION OF
50,000 SHARES OF CO'S STOCK & POTENTIAL EARNOUT CONSIDERATION OF
UP TO ABOUT $7.1 MILLION
Source text for Eikon: ID:nGNX3lYGzl
Further company coverage: EYEG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing